Frontlight ResearchEarly access
Trial site
Northwest Cancer Specialists, P.C.
- 11running trials
- 6closed trials
The trials here
What the 17 trials at this site are about, from their registry records.
- Conditions
- Lung cancer6 trials
- Colorectal cancer5 trials
- Endometrial cancer2 trials
- Liver and biliary tract cancer2 trials
- Bladder cancer1 trial
- Cervical cancer1 trial
- Gastric and oesophageal cancer1 trial
- Kidney cancer1 trial
- Metastatic breast cancer1 trial
- Phase
- Phase 36 trials
- Phase 24 trials
- Phase 1/23 trials
- Phase 2/33 trials
- Status
- Recruiting7 trials
- Completed5 trials
- Active, not recruiting4 trials
- Terminated1 trial
- Lead sponsor
- Pfizer5 trials
- Seagen, a wholly owned subsidiary of Pfizer3 trials
- Acrivon Therapeutics1 trial
- BioNTech SE1 trial
- Bristol-Myers Squibb1 trial
- and 6 more
Running trials
Recruiting
Recruiting
Recruiting
Recruiting
Recruiting
Active, not recruiting
A Study of SGN-B6A Versus Docetaxel in Previously Treated Non-small Cell Lung Cancer
Recruiting
Active, not recruiting
Recruiting
Active, not recruiting
Active, not recruiting
Basket Study of Tucatinib and Trastuzumab in Solid Tumors With HER2 Alterations
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Colorectal cancer2 recruiting
- Lung cancer2 recruiting
- Bladder cancer1 recruiting
- Endometrial cancer1 recruiting
- Kidney cancer1 recruiting
Closed trials
Recruiting
Quaratusugene Ozeplasmid (Reqorsa) and Atezolizumab Maintenance Therapy in ES-SCLC Patients
Recruiting
Completed
Completed
Completed
Completed
Site data: ClinicalTrials.govUpdated 12 Nov 2026